Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Method May Enable Portable Detection of ‘Bath Salts’

By Drug Discovery Trends Editor | September 10, 2014

Identifying potent drugs called “bath salts” with a handheld device could soon be a reality. (Source: ACS/DEA)Despite being outlawed in 2012 in the U.S., the synthetic drugs known as “bath salts”— which really aren’t meant for your daily bath— are still readily available in some retail shops, on the Internet and on the streets. To help law enforcement, scientists are developing a novel method that could be the basis for the first portable, on-site testing device for identifying the drugs. They report their advance in the ACS journal Analytical Chemistry.
 
Craig Banks, of Manchester Metropolitan University, in collaboration with Oliver Sutcliffe, notes that the high-inducing substances in bath salts, which are synthetic cathinones that also go by “plant food,” “glass cleaner” and a number of other innocuous-sounding names, are derived from a stimulant in a plant called khat. The plant is found on the Arabian Peninsula and East Africa. The drugs’ effects are similar to those of amphetamines.
 
Users reportedly feel an initial sense of euphoria, but this is followed by unpredictable and potentially dangerous effects, including seizures and hallucinations. Since bath salts first appeared in Europe and the U.S. more than four years ago, alarming reports emerged of users becoming violent. Tens of thousands of emergency room visits and several deaths have been attributed to the substances.
 
Scientists have been working successfully on different techniques to identify the synthetic drugs, but the methods aren’t portable. One group turned to an electrochemical approach, which can be adapted for in-the-field use, but their technique involved toxic mercury as the electrode. Banks’ team wanted to find a better, safer way to perform bath salts “fingerprinting.”
 
Using more environmentally friendly, mercury-free electrodes, the researchers developed a low-cost, disposable and rapid platform that could someday be used in a handheld sensor for detecting bath salts. They validated their technique using samples that were obtained from Internet vendors. The accuracy of their results matched that of established methods.
 
Date: September 10, 2014
Source: ACS
 

Filed Under: Drug Discovery

 

Related Articles Read More >

Tiffany Hurd
CB Therapeutics biz dev lead sees upside for psychedelics in mental health and beyond
Pharmacovigilance
A new era of pharmacovigilance: Worldwide master key for drug safety monitoring
Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50